Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The extracellular glycoproteins in the dental calculus matrix constitute the organic framework of mineralized dental plaque, commonly known as tartar. This matrix is a heterogeneous mixture of host-derived salivary proteins—such as mucins, proline-rich proteins (PRPs), and osteopontin—and microbial products that provide a structural scaffold for the deposition of calcium phosphate crystals (J. Periodontal Res., 2019). These glycoproteins play a dual role: they facilitate the initial adhesion of bacteria to the tooth surface and act as templates or inhibitors for biomineralization depending on their phosphorylation state and concentration (NIH/NIDCR, 2022). In clinical practice, this matrix is not a single therapeutic target but rather a complex environment targeted by anti-calculus agents found in oral care products. Drugs like pyrophosphates and zinc salts work by binding to the mineralizing front of the matrix to inhibit further crystal growth, while antimicrobial agents like triclosan reduce the bacterial load that contributes to the matrix's formation (J. Clin. Dent., 2009). Understanding the proteomic composition of these glycoproteins is vital for developing targeted therapies to prevent periodontal disease, as the hardened calculus serves as a reservoir for pathogenic bacteria that trigger chronic inflammation of the gingival tissues.
Inhibition of calcium phosphate crystal growth on the organic scaffold; disruption of the biofilm precursor (dental plaque); chelation of mineral ions to prevent binding to the glycoprotein matrix.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Extracellular glycoproteins in dental calculus matrix.